TY  - BOOK
AU  - Jonnalagadda, Anil K
TI  - Use, Safety and Effectiveness of Subintimal Angioplasty and Re-Entry Devices for the Treatment of Femoropopliteal Chronic Total Occlusions: A Systematic Review of 87 Studies and 4,665 Patients
SN  - 1878-0938
PY  - 2020///
KW  - *Angioplasty/is [Instrumentation]
KW  - *Femoral Artery
KW  - *Peripheral Arterial Disease/th [Therapy]
KW  - *Popliteal Artery
KW  - *Vascular Access Devices
KW  - Aged
KW  - Aged, 80 and over
KW  - Angioplasty/ae [Adverse Effects]
KW  - Chronic Disease
KW  - Constriction, Pathologic
KW  - Equipment Design
KW  - Female
KW  - Femoral Artery/dg [Diagnostic Imaging]
KW  - Femoral Artery/in [Injuries]
KW  - Femoral Artery/pp [Physiopathology]
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Peripheral Arterial Disease/dg [Diagnostic Imaging]
KW  - Peripheral Arterial Disease/pp [Physiopathology]
KW  - Popliteal Artery/dg [Diagnostic Imaging]
KW  - Popliteal Artery/in [Injuries]
KW  - Popliteal Artery/pp [Physiopathology]
KW  - Risk Factors
KW  - Time Factors
KW  - Treatment Outcome
KW  - Vascular Patency
KW  - Vascular System Injuries/et [Etiology]
KW  - MedStar Washington Hospital Centerumar
KW  - Medicine/General Internal Medicine
KW  - Journal Article
N1  - Available in print through MWHC library: 2002 - present
N2  - BACKGROUND: Subintimal angioplasty (SIA) is often utilized to cross femoropopliteal (FP) artery chronic total occlusions (CTOs). Re-entry devices (RED) can further assist with true lumen re-entry; CONCLUSION: SIA with or without RED is a valuable alternative to intraluminal crossing for endovascular treatment of FP CTOs. Procedural success was excellent for both techniques, while the cumulative complication rate was numerically lower in the RED group. Short- and long-term outcomes were acceptable for both techniques; Copyright (c) 2019. Published by Elsevier Inc; METHODS: A systematic review according to the PRISMA guidelines was performed. Quantitative synthesis was applied when possible; OBJECTIVE: To systematically review the literature for studies reporting on the use of SIA, with or without RED; RESULTS: 87 studies and 4665 patients (5161 lesions) were included (63.9% male). 46.7% of patients had critical limb ischemia at the time of the intervention. Two RED types were used (Pioneer and Outback). Sixty-eight studies included lesions treated with SIA without RED, 17 studies included lesions treated with RED only, and two studies included a comparison between the two treatment methods. In total, 3898 (83.6%) patients were treated with SIA without RED and 754 (12.2%) with RED. Procedural success rate ranged from 64.5%-100% (92.5% for SIA without RED, 88.3% for RED cases). The complication rate ranged from 1.6% - 28% among different studies (cumulative rates: SIA: 9.1%, RED 9.3%). Perforations occurred in 1.6% of the total population (n=46). Primary patency at one year ranged from 22% to 94.1%. Newer studies had a higher patency rate, ranging from 70% to 94.1%
UR  - https://dx.doi.org/10.1016/j.carrev.2019.03.016
ER  -